Therefore, by constructing AF rat models and obtaining CFs via isolation, we investigated whether miR-10a could mediate TGF-β1/Smads signaling to regulate cardiac fibrosis in AF, thus providing a novel theoretical foundation for the clinical treatment of AF. This evidence concerns the gene TGFB1 and atrial fibrillation.